Why Choose Painted Rock Health and Wellness
For patients with type 2 diabetes or obesity who are interested in GLP-1 therapies, discuss the currently licensed options with your GP, practice nurse, or diabetes specialist nurse
Methods Study design and PLIS cohort Participants of the risk-stratified, randomized, controlled and multicenter PLIS were recruited between 1 March 2012 and 31 August 2016 to assess potential superiority of an intensified LI compared to conventional DPP-based LI in improving glucose tolerance in people with prediabetes at high risk for T2D development
"Others may require dose escalation or maximal doses to experience an effect, and studies show that 20% of individuals are complete non-responders, meaning they do not experience any weight reduction despite maximal doses of the drug." With this in mind, the average experience with GLP-1s includes "a gradual onset of benefits," says Dr
While these effects can promote weight loss, they may also result in early feelings of fullness, nausea, diarrhea, or constipation